AzTrials
AzTrials

Cardiac Surgery, ReadmissionNCT06038266

Predictors of Hospital Readmission for Patients Undergoing Cardiac Surgeries

An observational study of Cardiac Surgery, Readmission, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aimed to identify the predictors of hospital readmission for patients undergoing cardiac surgeries. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Cardiac Surgery, Readmission
What is being tested?
cardiac surgeries
Type of treatment
Surgery or procedure
How many people
121 participants
Where
No sites listed yet
Study dates
Sep 2023to Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Adult, Older adult

Study population: The study will include a sample of 121 adult patients (male and female) who are undergoing CABG or Cardiac Valvular surgeries and whose age is from 18 to 65 years old.

Who may be able to join

  • The study will include a sample of 121 adult patients (male and female) who are undergoing CABG or Cardiac Valvular surgeries and whose age is from 18 to 65 years old.

Who cannot join

  • Failed surgery
  • Psychiatric patient
  • Patient refusal to participate in the study
  • Aortic surgeries

Trial locations and contacts

No sites are listed yet.

Mahmoud FathI Abdelhafeez Soliman, BSN contact

+201006579808

mahmoud808@aun.edu.eg

About this study

This study aimed to identify the predictors of hospital readmission for patients undergoing cardiac surgeries.

Read the detailed description

Cardiovascular diseases (CVDs) are conditions of the heart and blood vessels that lead to significant morbidity and mortality, burden the global public health system, and are the main cause of death worldwide. CVD accounted for approximately 19.05 million global deaths in 2020. CVD is listed as the first underlying cause of death, with more than 800000 deaths in the United States in 2019. Between 2015 and 2018, 126.9 million US adults had some form of CVD. Between 2017 and 2018, direct and indirect costs of total CVD were $378.0 billion ($226.2. billion in direct costs and $151.8 billion in lost productivity/mortality).

Cardiac surgery continues to play an important role in the management of various cardiovascular disorders, including the treatment of seriously and critically ill patients. The most frequently performed procedures include coronary artery bypass graft (CABG) and valvular surgery. According to the Society of Thoracic Surgeons, the number of cardiac surgeries exceeds 300000 procedures in 2019 in the United States. Despite tremendous advancements in cardiac surgery over the past few years, postoperative hospital readmissions after cardiac surgeries still present significant challenges.

Readmission occurs when a patient is admitted to the same or a different hospital after being discharged from the relevant hospital and placed in a non-acute setting, such as his home, within a predetermined amount of time. Readmission within 30 days of adult cardiac surgery is a difficult and costly problem, with rates ranging from 8% to 21%. In addition to delayed return to activities of daily living and reduced quality of life, readmission is associated with a financial cost for patients and healthcare facilities. Increased facility costs can be substantial, especially when combined with reimbursement penalties, the cost of skilled care, and potential legal expenses.

Readmission after cardiac surgery is common and moderately predictable. According to a study done in a multi-institutional hospital in Ontario, Canada on patients who underwent CABG and/or valve surgery from 2008 to 2016, the 30-day readmission rate was 11.5% overall. Patients who were readmitted were older with higher incidences of cardiac comorbidities compared with non-readmitted patients. Significant risk factors for readmission from the final model were the prolonged length of stay, isolated valve surgery, in-hospital complications of sepsis, acute myocardial infarction, diabetes mellitus, gastrointestinal problems wound infection, postoperative acute renal failure, atrial fibrillation (AF), chronic lung disease, obesity, hematocrit <35% before surgery, cardiopulmonary bypass, especially bypass durations of more than 100 minutes.

Perioperative nurses may positively affect reducing readmission rates at different stages of the perioperative continuum of care. All nursing interventions play an important role in minimizing patient risk and preventing or reducing the number of readmissions. Nursing strategies to reduce postoperative cardiac surgery readmission include central line and urinary catheter insertion, cardiopulmonary bypass circuit maintenance, temperature regulation, hair removal, and skin preparation, glycemic control, care of the incision site, treatment and prevention of dysrhythmia, pleural effusion and retained blood syndrome, appropriate discharge teaching, following up with the patients after discharge through telephone conversations and post-discharge care.

Reducing readmission after cardiac surgery remains a quality improvement priority. most readmission risk models examine only coronary artery bypass grafting (CABG). So, this study will be carried out to identify predictors of patients' postoperative readmission after cardiac surgery, including CABG \& valvular surgeries.

Being tested
cardiac surgeries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cardiac surgeriesProcedure or surgery

    predict perioperative risk factors for readmission after cardiac surgeries

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. detect perioperative risk factors for hospital readmission in patients whose undergoing cardiac surgeries

    analysis of pre, intra and postoperative risk factors that may cause readmission for patients undergoing Valvular surgery or Coronary artery bypass grafting (CABG)

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2023
  2. Study startSep 2023 (estimated)
  3. Primary completionMar 2024 (estimated)
  4. Study completionApr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
121 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06038266
Sponsor's protocol ID
PHR for Cardiac Surgery
Status last verified
Sep 2023
First submitted
8 Sep 2023
Last updated
14 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated device
No
Individual data sharing
No

Publications

  • Iribarne A, Chang H, Alexander JH, Gillinov AM, Moquete E, Puskas JD, Bagiella E, Acker MA, Mayer ML, Ferguson TB, Burks S, Perrault LP, Welsh S, Johnston KC, Murphy M, DeRose JJ, Neill A, Dobrev E, Baio KT, Taddei-Peters W, Moskowitz AJ, O'Gara PT. Readmissions after cardiac surgery: experience of the National Institutes of Health/Canadian Institutes of Health research cardiothoracic surgical trials network. Ann Thorac Surg. 2014 Oct;98(4):1274-80. doi: 10.1016/j.athoracsur.2014.06.059. Epub 2014 Aug 28.

    PubMed 25173721
  • Seifert PC. Reducing Readmissions After Coronary Artery Bypass Grafting. AORN J. 2017 Oct;106(4):332-337. doi: 10.1016/j.aorn.2017.08.009. No abstract available.

    PubMed 28958319
  • Ferraris VA, Ferraris SP, Harmon RC, Evans BD. Risk factors for early hospital readmission after cardiac operations. J Thorac Cardiovasc Surg. 2001 Aug;122(2):278-86. doi: 10.1067/mtc.2001.114776.

    PubMed 11479500
  • Demissie, D. B., Doge, G., & Werba, T. B. (2023). The Magnitude of 30-Day Readmission and Factors Associated with Patients Underwent Cardiac Surgery in Tikur Anbessa Specialized Hospital Cardiac Center, Ethiopia. Research Reports in Clinical Cardiology, Volume 14, 35-48. https://doi.org/10.2147/rrcc.s407183

  • Stephens RS, Whitman GJ. Postoperative Critical Care of the Adult Cardiac Surgical Patient. Part I: Routine Postoperative Care. Crit Care Med. 2015 Jul;43(7):1477-97. doi: 10.1097/CCM.0000000000001059.

    PubMed 25962078

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Surgery, Readmission, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mahmoud FathI Abdelhafeez Soliman, BSN (+201006579808, mahmoud808@aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

detect perioperative risk factors for hospital readmission in patients whose undergoing cardiac surgeries (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06038266, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in